Also listed on Metaproteomics, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Dec 22, 2025 (Whitehorse Capital Origination, LLC).
Term ends Feb 13, 2028 · High confidence
20-year base term ends Feb 13, 2028
Held by Metagenics LLC
Filed Jan 18, 2012 as application 13/352,831 · Granted Jul 2, 2013
Base term, 20 years from filing
Today
2008
2028
Clock starts
Feb 13, 2008
Feb 13, 2008
Term ends
Feb 13, 2028
Feb 13, 2028
Granted
Jul 2, 2013
Jul 2, 2013
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,241,674, to Feb 13, 2028. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 13, 2008, when application 12/030,335, the earliest non-provisional in its chain, was filed (this one was filed Jan 18, 2012) | Feb 13, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,241,674) | resolves to Feb 13, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 13, 2028 | High confidence |
This family
| US 8,241,674 | In force Dec 2028 | Dec 2028 |
| US 8,475,850 | this patent Feb 2028 | Feb 2028 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 14, 2012 Reel 27698, frame 470 | Tripp, Matthew L.; Konda, Veera; Hall, Amy; Desai, Anu; Bland, Jeffrey S. | Metaproteomics, LLC | Assignment of Assignor's Interest |
| Nov 1, 2021 Reel 57981, frame 156 | Metagenics, Inc.; Metaproteomics, LLC | Fortress Credit Corp., as Collateral Agent | Security Interest |
| Nov 4, 2021 Reel 58015, frame 602 | Metagenics, Inc.; Metaproteomics, LLC | Fortress Credit Corp. (as Collateral Agent) | Security Interest |
| Feb 16, 2024 Reel 66485, frame 677 | Metaproteomics, LLC | Metagenics LLC | Assignment of Assignor's Interest |
| Dec 22, 2025 Reel 73293, frame 381 | Metagenics LLC | Whitehorse Capital Origination, LLC, as Agent | Security Interest |
| Dec 23, 2025 Reel 74050, frame 670 | Fortress Credit Corp. | Metagenics LLC (FKA Metagenics, Inc.); Metaproteomics, LLC | Termination and Release of Patent Security Agreement - Reel/Frame 058015/0602 |
| Dec 23, 2025 reel/frame not recorded | Fortress Credit Corp. | Metagenics LLC (FKA Metagenics, Inc.) | Termination and Release of Patent Security Agreement - Reel/Frame 058015/0602 |
| Dec 23, 2025 reel/frame not recorded | Fortress Credit Corp. | Metaproteomics, LLC | Termination and Release of Patent Security Agreement - Reel/Frame 058015/0602 |
| Dec 24, 2025 Reel 74057, frame 392 | Fortress Credit Corp. | Metagenics LLC (FKA Metagenics, Inc.); Metaproteomics, LLC | Termination and Release of Patent Security Agreement - Reel/Frame 057981/0156 |
| Dec 24, 2025 reel/frame not recorded | Fortress Credit Corp. | Metagenics LLC (FKA Metagenics, Inc.) | Termination and Release of Patent Security Agreement - Reel/Frame 057981/0156 |
| Dec 24, 2025 reel/frame not recorded | Fortress Credit Corp. | Metaproteomics, LLC | Termination and Release of Patent Security Agreement - Reel/Frame 057981/0156 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Feb 2028
Term ends Feb 13, 2028. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,241,674, ends no earlier than this term, so it caps nothing.
Citations
5
later US patents cite this one
That is below the median of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.